Biocardia Stock Fundamentals
BioCardia fundamentals help investors to digest information that contributes to BioCardia's financial success or failures. It also enables traders to predict the movement of BioCardia Stock. The fundamental analysis module provides a way to measure BioCardia's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioCardia stock.
BioCardia |
BioCardia Company Number Of Shares Shorted Analysis
BioCardia's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current BioCardia Number Of Shares Shorted | 4.26 K |
Most of BioCardia's fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioCardia is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
CompetitionBased on the recorded statements, BioCardia has 4.26 K of outstending shares currently sold short by investors. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The number of shares shorted for all United States stocks is notably lower than that of the firm.
BioCardia Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BioCardia's current stock value. Our valuation model uses many indicators to compare BioCardia value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioCardia competition to find correlations between indicators driving BioCardia's intrinsic value. More Info.BioCardia is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value BioCardia by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.BioCardia Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioCardia's direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BioCardia could also be used in its relative valuation, which is a method of valuing BioCardia by comparing valuation metrics of similar companies.BioCardia is currently under evaluation in number of shares shorted category among its peers.
BioCardia Fundamentals
| Return On Equity | -7.04 | |||
| Return On Asset | -1.33 | |||
| Operating Margin | (41.36) % | |||
| Number Of Shares Shorted | 4.26 K | |||
| Revenue | 477 K | |||
| EBITDA | (11.23 M) | |||
| Net Income | (11.57 M) | |||
| Total Debt | 1.31 M | |||
| Book Value Per Share | (1.27) X | |||
| Cash Flow From Operations | (9.97 M) | |||
| Earnings Per Share | (3.20) X | |||
| Number Of Employees | 16 | |||
| Beta | 1.37 | |||
| Total Asset | 2.99 M | |||
| Retained Earnings | (152.18 M) | |||
| Working Capital | (2.15 M) | |||
| Net Asset | 2.99 M |
About BioCardia Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BioCardia's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioCardia using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioCardia based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in BioCardia Stock
If you are still planning to invest in BioCardia check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioCardia's history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |